Latest Insider Transactions at Ra Pharmaceuticals, Inc. (RARX)
This section provides a real-time view of insider transactions for Ra Pharmaceuticals, Inc. (RARX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ra Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ra Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2020
|
Ra Capital Management, L.P. Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,858,260
-100.0%
|
$233,196,480
$48.0 P/Share
|
|
Dec 12
2018
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
1,006,452
+17.16%
|
$15,096,780
$15.5 P/Share
|
|
Feb 14
2018
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
2,500,000
+39.36%
|
$15,000,000
$6.0 P/Share
|
|
Jun 19
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,220
-0.14%
|
$70,840
$22.02 P/Share
|
|
Jun 16
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53,200
-2.31%
|
$1,117,200
$21.24 P/Share
|
|
Jun 08
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
700
-0.03%
|
$15,400
$22.0 P/Share
|
|
Jun 07
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,840
-0.21%
|
$106,480
$22.11 P/Share
|
|
Jun 06
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,274
-0.31%
|
$160,028
$22.98 P/Share
|
|
Jun 05
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,780
-0.21%
|
$109,940
$23.11 P/Share
|
|
Jun 02
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,867
-0.64%
|
$341,941
$23.47 P/Share
|
|
Jun 01
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,722
-0.46%
|
$246,606
$23.89 P/Share
|
|
May 31
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
35,539
-1.49%
|
$817,397
$23.94 P/Share
|
|
May 26
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,300
-0.22%
|
$132,500
$25.14 P/Share
|
|
May 25
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
53
-0.0%
|
$1,325
$25.0 P/Share
|
|
May 24
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,451
-0.72%
|
$436,275
$25.01 P/Share
|
|
May 18
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,019
-0.37%
|
$225,475
$25.5 P/Share
|
|
May 17
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,534
-0.92%
|
$563,350
$25.51 P/Share
|
|
May 16
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,081
-0.82%
|
$522,106
$26.33 P/Share
|
|
Mar 01
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,778
-0.32%
|
$155,560
$20.91 P/Share
|
|
Feb 28
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,847
-0.32%
|
$156,940
$20.86 P/Share
|
|
Feb 27
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
57,844
-2.28%
|
$1,156,880
$20.96 P/Share
|
|
Feb 24
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,398
-0.21%
|
$107,960
$20.93 P/Share
|
|
Feb 23
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,999
-0.2%
|
$104,979
$21.04 P/Share
|
|
Feb 22
2017
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
749
-0.03%
|
$15,729
$21.86 P/Share
|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
84,615
+3.22%
|
$1,099,995
$13.0 P/Share
|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,398,462
+28.77%
|
-
|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
339
-0.54%
|
$4,407
$13.0 P/Share
|
|
Oct 31
2016
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
62,914
+50.0%
|
$0
$0.07 P/Share
|